Joel A Sincavage

Array ( [id] => 8490172 [patent_doc_number] => 20120289579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'IMPAIRED WOUND HEALING COMPOSITIONS AND TREATMENTS' [patent_app_type] => utility [patent_app_number] => 13/295020 [patent_app_country] => US [patent_app_date] => 2011-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22010 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13295020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186897 [patent_doc_number] => 20120115930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'COMPOSITIONS AND THEIR USES DIRECTED TO HEPCIDIN' [patent_app_type] => utility [patent_app_number] => 13/294068 [patent_app_country] => US [patent_app_date] => 2011-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16442 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115930.pdf [firstpage_image] =>[orig_patent_app_number] => 13294068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9122172 [patent_doc_number] => 20130289094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'Compositions and Methods for Inhibition of PCSK9 Genes' [patent_app_type] => utility [patent_app_number] => 13/882473 [patent_app_country] => US [patent_app_date] => 2011-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 52724 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703899 [patent_doc_number] => 08828961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Methods and compositions to protect aquatic invertebrates from disease' [patent_app_type] => utility [patent_app_number] => 13/277066 [patent_app_country] => US [patent_app_date] => 2011-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 35728 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13277066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9122336 [patent_doc_number] => 20130289258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'METHODS OF INDUCING INSULIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 13/877968 [patent_app_country] => US [patent_app_date] => 2011-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 28849 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8241164 [patent_doc_number] => 20120149893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'MODULATION OF EIF4E-BP2' [patent_app_type] => utility [patent_app_number] => 13/267805 [patent_app_country] => US [patent_app_date] => 2011-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24030 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13267805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744649 [patent_doc_number] => 20120022140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Method of treating a cancer with a survivin antisense oligonucleotide and paclitaxel' [patent_app_type] => utility [patent_app_number] => 13/246890 [patent_app_country] => US [patent_app_date] => 2011-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4787 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022140.pdf [firstpage_image] =>[orig_patent_app_number] => 13246890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003057 [patent_doc_number] => 20130224182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/247882 [patent_app_country] => US [patent_app_date] => 2011-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21787 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13247882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733237 [patent_doc_number] => 20120015850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'siRNA targeting Superoxide' [patent_app_type] => utility [patent_app_number] => 13/199946 [patent_app_country] => US [patent_app_date] => 2011-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34529 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015850.pdf [firstpage_image] =>[orig_patent_app_number] => 13199946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676910 [patent_doc_number] => 08815819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Anti-connexin compounds targeted to connexins and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/230744 [patent_app_country] => US [patent_app_date] => 2011-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 38816 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13230744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10039236 [patent_doc_number] => 09079934 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Antisense nucleic acids' [patent_app_type] => utility [patent_app_number] => 13/819520 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18248 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10090467 [patent_doc_number] => 09127280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'Oligonucleotide, and therapeutic agent for dyslipidemia containing oligonucleotide as active ingredient' [patent_app_type] => utility [patent_app_number] => 13/819722 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 34 [patent_no_of_words] => 18803 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9227638 [patent_doc_number] => 08633306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'SiRNA targeting histamine receptor H1' [patent_app_type] => utility [patent_app_number] => 13/136780 [patent_app_country] => US [patent_app_date] => 2011-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 35757 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13136780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7790554 [patent_doc_number] => 20120052110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'METHODS AND COMPOSITIONS FOR PROMOTING WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 13/197833 [patent_app_country] => US [patent_app_date] => 2011-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16916 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20120052110.pdf [firstpage_image] =>[orig_patent_app_number] => 13197833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754674 [patent_doc_number] => 20120027791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'ANTISENSE COMPOUND FOR INDUCING IMMUNOLOGICAL TOLERANCE' [patent_app_type] => utility [patent_app_number] => 13/187338 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14807 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027791.pdf [firstpage_image] =>[orig_patent_app_number] => 13187338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778921 [patent_doc_number] => 20120041184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)' [patent_app_type] => utility [patent_app_number] => 13/179785 [patent_app_country] => US [patent_app_date] => 2011-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 69686 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041184.pdf [firstpage_image] =>[orig_patent_app_number] => 13179785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757142 [patent_doc_number] => 20120029050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'COMPOSITIONS AND THEIR USES DIRECTED TO DIACYLGLYCEROL ACYLTRANSFERASE 1' [patent_app_type] => utility [patent_app_number] => 13/177457 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15402 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029050.pdf [firstpage_image] =>[orig_patent_app_number] => 13177457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712316 [patent_doc_number] => 20120004403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)' [patent_app_type] => utility [patent_app_number] => 13/165635 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 66132 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13165635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254656 [patent_doc_number] => 08618072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease' [patent_app_type] => utility [patent_app_number] => 13/162226 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 28 [patent_no_of_words] => 10680 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13162226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7755727 [patent_doc_number] => 20120028348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'MULTIPLE RNA POLYMERASE III PROMOTER EXPRESSION CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 13/160774 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22274 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028348.pdf [firstpage_image] =>[orig_patent_app_number] => 13160774 [rel_patent_id] =>[rel_patent_doc_number] =>)